[PTGX] QoQ Quarter Result on 30-Jun-2021 [#Q2]

Stock
[PTGX] Protagonist Therapeutics, Inc.
Announcement Date
04-Aug-2021
Financial Year
2021
Quarter
30-Jun-2021 [#Q2]
Profit Trend
QoQ- -28.52%
YoY- -58.81%
Quarter Report
PTGX's Result
PTGX's Financial Summary
View:
Show?
Quarter Result
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Revenue 25,722 8,617 10,286 2,265 6,189 5,650 13,114 56.75%
PBT -20,930 -36,907 -33,804 -30,842 -23,998 -18,886 -7,763 93.83%
Tax -181 -832 122 -57 -79 -1,305 -40 173.82%
NP -20,749 -36,907 -33,804 -30,842 -23,998 -18,886 -7,763 92.71%
Tax Rate - - - - - - - -
Total Cost 46,471 45,524 44,090 33,107 30,187 24,536 20,877 70.56%
Ratio Analysis
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
NP Margin -80.67 -428.30 -328.64 -1,361.68 -387.75 -334.27 -59.20 22.93%
Per Share
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
EPS -0.43 -0.77 -0.70 -0.69 -0.54 -0.48 -0.21 61.32%
EPS Diluted -0.43 -0.77 -0.70 -0.69 -0.54 -0.48 -0.21 61.32%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.